Skip to content

6-KAccepted Oct 1, 6:42 AM ET

AgomAb Therapeutics NV 6-K

AGMBAgomAb Therapeutics NV

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

6:42 AM

Oct 1, 2026

Filed

Oct 1, 2026

Documents

3

Size

60.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.